Time to Study Immune Checkpoint Inhibitors in Patients With HIV Infection and Cancer
- 1 June 2020
- journal article
- editorial
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 16 (6), 327-328
- https://doi.org/10.1200/op.20.00074
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Safety and Efficacy of Immune Checkpoint Inhibitors in Patients With Cancer Living With HIV: A Perspective on Recent Progress and Future NeedsJCO Oncology Practice, 2020
- Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?AIDS, 2020
- Safety and Efficacy of Immune Checkpoint Inhibitor Therapy in Patients With HIV Infection and Advanced-Stage CancerJAMA Oncology, 2019
- Advances in cancer immunotherapy 2019 – latest trendsJournal of Experimental & Clinical Cancer Research, 2019